Two faces of carbon nanotube: toxicities and pharmaceutical applications
- PMID: 22356722
- DOI: 10.1615/critrevtherdrugcarriersyst.v29.i1.20
Two faces of carbon nanotube: toxicities and pharmaceutical applications
Abstract
In the field of nanotechnology, carbon nanotube (CNT) is gaining importance for the delivery of therapeutic agents and diagnosis of diseases. CNT is emerging as an efficient nanocarrier system with cylindrical nanostructure. Due to its nanoscale dimensions, CNTs have a high cell-penetration quality that allows its use in site-specific targeting. Another aspect of the utilization of CNT lies in its hollow structure through which an active moiety can be delivered in a controlled manner via CNTs' nano channels. Despite these positive aspects of CNT, scientists are still working to improve its biocompatibility and solubility and eliminating toxicity in vivo, which are creating problems with the use of CNTs. Therefore, functionalization becomes an important aspect to be studied because it decreases the toxicity of CNTs and make them nonimmunogenic. In this review, different functionalization techniques of CNTs and their biomedical applications-in particular for cancer therapy to date-are reviewed in detail to present the potential of this nanovector.
Similar articles
-
Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.Nanomedicine. 2008 Sep;4(3):183-200. doi: 10.1016/j.nano.2008.04.003. Epub 2008 Jun 11. Nanomedicine. 2008. PMID: 18550450 Review.
-
Biomedical Applications and Toxicological Aspects of Functionalized Carbon Nanotubes.Crit Rev Ther Drug Carrier Syst. 2018;35(4):293-330. doi: 10.1615/CritRevTherDrugCarrierSyst.2018014419. Crit Rev Ther Drug Carrier Syst. 2018. PMID: 29972680 Review.
-
Advanced biomedical applications of carbon nanotube.Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:616-630. doi: 10.1016/j.msec.2019.03.043. Epub 2019 Mar 13. Mater Sci Eng C Mater Biol Appl. 2019. PMID: 30948098 Review.
-
Carbon nanotubes: a potential concept for drug delivery applications.Recent Pat Drug Deliv Formul. 2014 Apr;8(1):12-26. doi: 10.2174/1872211308666140124095745. Recent Pat Drug Deliv Formul. 2014. PMID: 24456215 Review.
-
Carbon Nanotubes in Biomedical Applications: Factors, Mechanisms, and Remedies of Toxicity.J Med Chem. 2016 Sep 22;59(18):8149-67. doi: 10.1021/acs.jmedchem.5b01770. Epub 2016 May 27. J Med Chem. 2016. PMID: 27142556 Review.
Cited by
-
Nanomaterials in the application of tumor vaccines: advantages and disadvantages.Onco Targets Ther. 2013 Jun 5;6:629-34. doi: 10.2147/OTT.S41902. Print 2013. Onco Targets Ther. 2013. PMID: 23776336 Free PMC article.
-
PEGylated single-walled carbon nanotubes as nanocarriers for cyclosporin A delivery.AAPS PharmSciTech. 2013 Jun;14(2):593-600. doi: 10.1208/s12249-013-9944-2. Epub 2013 Mar 12. AAPS PharmSciTech. 2013. PMID: 23479049 Free PMC article.
-
Carbon nanotubes in biomedical applications: current status, promises, and challenges.Carbon Lett (Korean Carbon Soc). 2022;32(5):1207-1226. doi: 10.1007/s42823-022-00364-4. Epub 2022 Jul 4. Carbon Lett (Korean Carbon Soc). 2022. PMID: 40477687 Free PMC article. Review.
-
Safe clinical use of carbon nanotubes as innovative biomaterials.Chem Rev. 2014 Jun 11;114(11):6040-79. doi: 10.1021/cr400341h. Epub 2014 Apr 10. Chem Rev. 2014. PMID: 24720563 Free PMC article. Review. No abstract available.
-
Personalized nanomedicine advancements for stem cell tracking.Adv Drug Deliv Rev. 2012 Oct;64(13):1488-507. doi: 10.1016/j.addr.2012.07.008. Epub 2012 Jul 20. Adv Drug Deliv Rev. 2012. PMID: 22820528 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources